US Government Awards Moderna $176 Million for mRNA Bird Flu Vaccine
Publisher |
WIRED
Media Type |
audio
Categories Via RSS |
Business
Publication Date |
Jul 08, 2024
Episode Duration |
00:06:40

As fears of a pandemic mount, the biotech company’s mRNA vaccine trial is set to release Phase 1/2 results later this year, with a larger Phase 3 trial expected to begin in 2025.

This episode currently has no reviews.

Submit Review
This episode could use a review!

This episode could use a review! Have anything to say about it? Share your thoughts using the button below.

Submit Review